
Newsletter
Peptide Hope: Unlocking the MYC Mystery in Cancer Treatment
Imagine a world where the most challenging targets in cancer treatment become accessible. The MYC transcription factor, implicated in over 70% of human cancers, has been notoriously difficult to target due to its disordered structure and fast turnover rate. But now, a new generation of peptide libraries is changing the